It is a prescription - normal assumption is that it is not a single bottle but I don't know so won't commit to that definitively. Income from the prescription may come in over 12 months and not all at once.
This is why we need to look at the next quarterly report and see what revenue has been generated and maybe get a projection of what will come in over the next year.
200 prescriptions could mean that GP's are starting to develop some interest in dispensing CannEpil which has to be a positive.
MXC Price at posting:
4.0¢ Sentiment: None Disclosure: Not Held
